Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-26
DOI
10.3389/fonc.2021.685570
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer
- (2020) Lujing Yang et al. BRITISH JOURNAL OF CANCER
- The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers
- (2020) Mehmet Zengin et al. PATHOLOGY & ONCOLOGY RESEARCH
- Tumour–stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study
- (2020) Hao Dang et al. United European Gastroenterology Journal
- Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer
- (2019) Oscar G. F. Geessink et al. CELLULAR ONCOLOGY
- Cancer-associated fibroblasts in gastrointestinal cancer
- (2019) Hiroki Kobayashi et al. Nature Reviews Gastroenterology & Hepatology
- Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
- (2019) Tessa P. Sandberg et al. BMC CANCER
- Extramural spread of rectal cancer and the AJCC Cancer Staging Manual 8th edition, 2017
- (2019) R J Nicholls et al. ANNALS OF ONCOLOGY
- Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients
- (2019) Mehmet Zengin PATHOLOGY RESEARCH AND PRACTICE
- Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
- (2018) Stéphanie M. Zunder et al. BRITISH JOURNAL OF CANCER
- The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact
- (2018) Gabi W van Pelt et al. HISTOPATHOLOGY
- The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
- (2018) Ann Christina Eriksen et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Prevalence of frailty in Japan: A systematic review and meta-analysis
- (2017) Gotaro Kojima et al. JOURNAL OF EPIDEMIOLOGY
- Preoperative thrombocytosis predicts prognosis in stage II colorectal cancer patients
- (2016) Yong Sun Lee et al. Annals of Surgical Treatment and Research
- Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer
- (2016) J. H. Park et al. OncoImmunology
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer
- (2014) J. H. Park et al. ANNALS OF ONCOLOGY
- EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy
- (2014) M. Chand et al. ANNALS OF ONCOLOGY
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
- (2014) Carson Ka-Lok Lo et al. BMC Medical Research Methodology
- Physicians' Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer
- (2014) Anthony C. Wong et al. Journal of Oncology Practice
- Imaging aspects of the tumor stroma with therapeutic implications
- (2013) Lian Narunsky et al. PHARMACOLOGY & THERAPEUTICS
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
- (2012) A. Huijbers et al. ANNALS OF ONCOLOGY
- Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial
- (2012) Shin Fujita et al. LANCET ONCOLOGY
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
- (2010) N P West et al. BRITISH JOURNAL OF CANCER
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started